| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 01/26/2006 | US20060018915 Heteroclitic analogs and related methods |
| 01/26/2006 | US20060018906 monoclonal antibody for treating cancer, neovascularization, vascular and arthritic diseases; immunoassay; immunotherapy; inhibition or antagonism of TNF decreases expression of Vascular Endothelial Growth Factor (VEGF) or Vascular Permeability Factor (VPF); decrease angiogenesis |
| 01/26/2006 | US20060018905 Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof |
| 01/26/2006 | US20060018893 Method for determining modulation of P110delta activity |
| 01/26/2006 | US20060018892 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis |
| 01/26/2006 | US20060018889 Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes for gene therapy |
| 01/26/2006 | US20060018881 Coordinate in vivo gene expression |
| 01/26/2006 | US20060018859 Modified human serum albumin with reduced or eliminated affinity to chemical or biological contaminants at Cys 34 |
| 01/26/2006 | US20060018826 Biologic modulations with nanoparticles |
| 01/26/2006 | CA2573164A1 Detection of nucleic acids to assess risk for bovine spongiform encephalopathy |
| 01/26/2006 | CA2570872A1 Compositions and methods for enzymatic decolorization of chlorophyll |
| 01/26/2006 | CA2569191A1 C-met kinase binding proteins |
| 01/26/2006 | CA2569046A1 Aldos as modifiers of the igf pathway and methods of use |
| 01/26/2006 | CA2568012A1 Cdk9 as modifier of the igf pathway and methods of use |
| 01/25/2006 | EP1619259A2 Sequencing method using magnifying tags |
| 01/25/2006 | EP1619256A1 Microorganism staining agent and use thereof |
| 01/25/2006 | EP1619207A2 HLA-A2.1 binding peptides derived from HCV and their uses |
| 01/25/2006 | EP1618382A1 Improved composite microarry slides |
| 01/25/2006 | EP1618215A2 Oligonucleotides comprising a molecular switch |
| 01/25/2006 | EP1618195A2 Method for selective inhibition of human n-myc gene in n-myc expressing tumors through antisense and antigen peptido-nucleic acids (pna) |
| 01/25/2006 | EP1618189A2 Rnai agents for anti-sars coronavirus therapy |
| 01/25/2006 | EP1618181A2 Polyvalent protein complex |
| 01/25/2006 | EP1618124A2 Prophylactic and therapeutic benefits of new class of immune stimulating peptides |
| 01/25/2006 | EP1617829A2 Yeast ectopically expressing abnormally processed proteins and uses therefor |
| 01/25/2006 | EP1617802A2 Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses. |
| 01/25/2006 | EP1474430B1 Bi-functionalised metallocenes use for marking biological molecules |
| 01/25/2006 | EP1212462B1 Methods of determining the presence of double stranded nucleic acids in a sample |
| 01/25/2006 | CN1726226A Antibodies that bind cell-associated CA125/0722P and methods of use thereof |
| 01/25/2006 | CN1726223A Process for purifying oligonucleotide synthons |
| 01/25/2006 | CN1726046A Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
| 01/25/2006 | CN1724665A Human new gene TRIKS and its coded protein |
| 01/25/2006 | CN1724664A Human HOLF 402 protein and its coding sequence |
| 01/25/2006 | CN1238521C Uses of A section of man-type mycoplasma DNA sequence (4) |
| 01/25/2006 | CN1238510C Artificial synthetic Bt anti-insect gene used for transgene anti-insect plant and its development method |
| 01/25/2006 | CN1238507C 6 gene of neurenergen sourced from human, and application of maturation peptide fragment expressed by the gene |
| 01/25/2006 | CN1238504C Tumour related gene and use thereof |
| 01/25/2006 | CN1238503C Resistance gene of glyphosate as well as carrier and transformant containing gene |
| 01/25/2006 | CN1238379C New osteoclast formation inhibiting factor and its coding sequence and use |
| 01/25/2006 | CN1238375C Chlorine-ion/ bicarbonate radical exchange protein drived by sodium-ion |
| 01/25/2006 | CN1238370C Method for separating single biological macro molecule |
| 01/25/2006 | CN1238369C Pure honeysuckle polymerase chain reaction-restriction map identification method |
| 01/25/2006 | CN1238368C Gene for changing cotton fiber quantity and character and its encoding protein and use |
| 01/25/2006 | CN1238367C Isolated nucleic acid molecules which encode T cell inducible factors (TIF), proteins encoded, and uses thereof |
| 01/25/2006 | CN1238366C Selection of proteins using RNA-protein fusions |
| 01/25/2006 | CN1238365C EB virus antisense oligomeric deoxynucleotide and its application |
| 01/24/2006 | US6989442 Synthesizing nucleic acid, contacting with a alkylamine, loading mixture onto media and applying a purification gradient using a suitable elution buffer |
| 01/24/2006 | US6989441 Nucleotide sequences coding transport protein for use in the treatment of vision defcets, liver, cardiovascular, nervous system and cell proliferation disorders |
| 01/24/2006 | US6989374 Gene therapy for cardiomyopathy |
| 01/24/2006 | US6989365 Methods of treatment with erythropoietin and albumin fusion protein |
| 01/24/2006 | US6989275 Generating luminescent particles; generate reaction mixture containing biopolymers and cyanine dye, conjugate cyanine dye with biopolymer, evaluate signal from conjugate |
| 01/24/2006 | US6989270 Using polyamide nucleic acid oligomers to engender a biological response |
| 01/24/2006 | US6989267 Methods of making microarrays with substrate surfaces having covalently bound polyelectrolyte films |
| 01/24/2006 | US6989261 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 01/24/2006 | US6989257 Isoprenoid production |
| 01/24/2006 | US6989250 Isolation of nucleotide sequences coding preferential protein; obtain nucleotide sequences, mutate, incubate with oligonucleotide primers, amplify and isolate single-stranded nucleotide sequences, generate preferential nucleic acids |
| 01/24/2006 | US6989249 Extraction of nucleotide sequences from microorganisms; obtain microorganism, grind sample, embed in agarose, extract nucleotide sequences, expose to electrophoresis, extract nucleotide sequences |
| 01/24/2006 | US6989244 Method for screening compounds inhibiting signal transduction through inflammatory cytokines |
| 01/24/2006 | US6989233 Method and device for analyzing nucleic acids immobilized on a support |
| 01/24/2006 | US6989147 Tumor necrosis factor receptor protein for use in the treatment of arthritis |
| 01/24/2006 | US6989133 reactors comprising multicompartment apertures having seals; oligonucleotide synthesis |
| 01/23/2006 | WO2007015691A2 Methods and compositions for increasing longevity and protein yield from a cell culture |
| 01/19/2006 | WO2006007557A2 Ryegrass cbf3 gene : identification and isolation |
| 01/19/2006 | WO2006006948A2 METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY |
| 01/19/2006 | WO2006006734A1 Dna carrier, method of producing the same and collection system using the same |
| 01/19/2006 | WO2005108411A3 Substituted pixyl protecting groups for oligonucleotide synthesis |
| 01/19/2006 | WO2005089285A3 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing |
| 01/19/2006 | WO2005089123A3 Therapeutic anti-cancer dna |
| 01/19/2006 | WO2005076908A3 Anti-freeze protein enhanced nucleic acid amplification |
| 01/19/2006 | WO2005065268A3 Oligonucleotide compound and method for treating nidovirus infections |
| 01/19/2006 | WO2005035723A3 Tyrosinase mutant and methods of use thereof |
| 01/19/2006 | WO2005017149A8 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 01/19/2006 | US20060015973 Environmental stress-tolerant plants |
| 01/19/2006 | US20060015970 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 01/19/2006 | US20060015968 Nucleotide sequences mediating male fertility and method of using same |
| 01/19/2006 | US20060015966 Transgenic plant cells and plants having modified activity of the GBSSI and of the BE protein |
| 01/19/2006 | US20060015959 Transgenic animals expressing transglutaminase II |
| 01/19/2006 | US20060015958 Human artificial chromosome containing human antibody lambda light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission |
| 01/19/2006 | US20060015955 Alpha(1,3)Galactosyltransferase enzyme that assembles the Galalpha(1,3)Gal xenoantigen |
| 01/19/2006 | US20060015951 Proteins involved in the regulation of energy homeostasis |
| 01/19/2006 | US20060014942 Nucleotide sequences for the control of the expression of DNA sequences in a cell host |
| 01/19/2006 | US20060014941 Isolated T lymphocyte receptors specific for human autoantigens complexed with human MHC molecules and methods of making and using same |
| 01/19/2006 | US20060014940 Cloning and characterization of slc26a6, slc26a1, and slc26a2 anion exchangers |
| 01/19/2006 | US20060014936 Hybrid bacillus thuringiensis Cry1A/Cry1F DNA and plants and host cells transformed with same |
| 01/19/2006 | US20060014931 Novel promoter |
| 01/19/2006 | US20060014688 Methods of inhibiting tumor cell proliferation |
| 01/19/2006 | US20060014687 Bone delivery conjugates and method of using same to target proteins to bone |
| 01/19/2006 | US20060014683 Procoagulant protein comprising polypeptide with amino acid substitutions; resistant to activated protein C; von Willebrand factor binding site deleted and thrombin cleavage site is mutated; treating hemophilia |
| 01/19/2006 | US20060014679 Drug screening; diabetes, obesity, hyperlipemia, arteriosclerosis, hypertension, cardiovascular disorders |
| 01/19/2006 | US20060014668 Antigenic gp 100 compounds for therapy and diagnosis and methods of using same |
| 01/19/2006 | US20060014277 Novel human kielin-like proteins and polynucleotides encoding the same |
| 01/19/2006 | US20060014265 Mutant alpha-amylases |
| 01/19/2006 | US20060014262 Beta1,3-galactosyltransferase and DNA encoding the same |
| 01/19/2006 | US20060014254 Albumin fusion proteins |
| 01/19/2006 | US20060014253 Lamprey GnRH-III polypeptides and methods of making thereof |
| 01/19/2006 | US20060014252 Flk-1 binding protein |
| 01/19/2006 | US20060014251 Alternatively spliced isoform of calcium channel, voltage dependent, alpha-II subunit (CACNA1I) |
| 01/19/2006 | US20060014249 Human G-protein coupled receptor |
| 01/19/2006 | US20060014248 Tumor Necrosis Factor Super Family (TNFSF) with antagonist activity ; for autoimmune conditions |
| 01/19/2006 | US20060014247 DNA constructs for obtaining in a filamentous fungus host (actinomycete) a higher production level of a carbohydrate degrading (CD) enzyme, having in its original state a catalytic module (CAT) and a carbohydrate binding module (CBM) separated by a linker region; Xylanase; use in paper industry |
| 01/19/2006 | US20060014246 Canine cold- and menthol-sensitive receptor 1 |